Country Daily
Greater China Strategy-Alpha Picks September Conviction Calls / China Internet AI Capex
Analyst
Key Indices



Top Stories
Strategy | Alpha Picks: September Conviction Calls
Chinese equities consolidated in August, with the HSI and MSCI China Index dipping 1.2% mom and 0.4% mom, respectively. We remain positive on TMT and IT hardware, and add Han’s Laser, Innovent, NAURA and Tencent to our BUY list. We take profit on BeOne Medicines, and cut losses on EVE Energy, Hesai and Trip.com.
Sector Update | Internet
AI/AI cloud remained the bright spot in 2Q26, with Alibaba and Baidu delivering 45%/50% yoy revenue growths in AI cloud respectively and Tencent reporting healthy cloud growth on AI demand. However, the surging capex and Alibaba’s HK$80b (US$10.3b) placement shifts the AI debate from project returns to funding duration and capital structure. The investment cycle is pressuring near-term FCF, but stronger utilisation, proprietary chips and higher-margin AI services should improve compute economics over time. Maintain MARKET WEIGHT. Top BUY: Alibaba.
Top Stories
Strategy | Alpha Picks: September Conviction Calls
Chinese equities consolidated in August, with the HSI and MSCI China Index dipping 1.2% mom and 0.4% mom, respectively. We remain positive on TMT and IT hardware, and add Han’s Laser, Innovent, NAURA and Tencent to our BUY list. We take profit on BeOne Medicines, and cut losses on EVE Energy, Hesai and Trip.com.
Sector Update | Internet
AI/AI cloud remained the bright spot in 2Q26, with Alibaba and Baidu delivering 45%/50% yoy revenue growths in AI cloud respectively and Tencent reporting healthy cloud growth on AI demand. However, the surging capex and Alibaba’s HK$80b (US$10.3b) placement shifts the AI debate from project returns to funding duration and capital structure. The investment cycle is pressuring near-term FCF, but stronger utilisation, proprietary chips and higher-margin AI services should improve compute economics over time. Maintain MARKET WEIGHT. Top BUY: Alibaba.
Analyst
Key Indices



IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.



